Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CPH

Cipher Pharmaceuticals (CPH)

Cipher Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:CPH
DateTimeSourceHeadlineSymbolCompany
05/03/20246:05AMPR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
03/14/20244:00PMPR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 ResultsTSX:CPHCipher Pharmaceuticals Inc
03/08/20246:00AMPR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
01/29/202411:56AMAllPennyStocks.comWill Uplisting Be the Catalyst to Send Sharesof this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
01/29/202411:56AMAllPennyStocks.comWill Uplisting Be the Catalyst to Send Shares of this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
01/29/20246:15AMPR Newswire (Canada)Cipher Pharmaceuticals Announces the Commencement of OTCQX TradingTSX:CPHCipher Pharmaceuticals Inc
11/24/20234:00PMPR Newswire (Canada)Cipher Pharmaceuticals Announces Change of AuditorTSX:CPHCipher Pharmaceuticals Inc
11/15/20234:00PMPR Newswire (Canada)Cipher Pharmaceuticals Announces Normal Course Issuer BidTSX:CPHCipher Pharmaceuticals Inc
11/09/20234:00PMPR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023TSX:CPHCipher Pharmaceuticals Inc
10/27/20236:00AMPR Newswire (Canada)Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
10/12/20238:57AMPR Newswire (Canada)Cipher Pharmaceuticals Announces Final Results of Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
10/03/20236:00AMPR Newswire (Canada)Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
09/05/20236:00AMPR Newswire (Canada)Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian DollarsTSX:CPHCipher Pharmaceuticals Inc
08/10/20234:00PMPR Newswire (Canada)Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in MexicoTSX:CPHCipher Pharmaceuticals Inc
07/28/20236:00AMPR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
07/05/20236:00AMPR Newswire (Canada)Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European UnionTSX:CPHCipher Pharmaceuticals Inc
06/21/202311:53AMPR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of ShareholdersTSX:CPHCipher Pharmaceuticals Inc
05/11/20234:00PMPR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial FlexibilityTSX:CPHCipher Pharmaceuticals Inc
05/04/20234:00PMPR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
03/16/20234:00PMPR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
03/10/20234:30PMPR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
03/01/20236:00AMPR Newswire (Canada)Cipher Pharmaceuticals Announces Closing of New US$35 Million Credit FacilityTSX:CPHCipher Pharmaceuticals Inc
11/10/20225:30PMPR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per ShareTSX:CPHCipher Pharmaceuticals Inc
10/26/20226:00AMPR Newswire (Canada)CIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALLTSX:CPHCipher Pharmaceuticals Inc
09/19/20224:00PMPR Newswire (Canada)Cipher Pharmaceuticals Announces Normal Course Issuer BidTSX:CPHCipher Pharmaceuticals Inc
08/11/20224:45PMPR Newswire (Canada)Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFOTSX:CPHCipher Pharmaceuticals Inc
08/11/20224:01PMPR Newswire (Canada)Cipher Pharmaceuticals Reports Second Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
08/05/20226:00AMPR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
06/22/20224:01PMPR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John MullTSX:CPHCipher Pharmaceuticals Inc
05/12/20224:00PMPR Newswire (Canada)Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
 Showing the most relevant articles for your search:TSX:CPH